tazobactam has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C | 1 |
| Béraud, G; Bouchand, F; Canouï, E; Davido, B; Dinh, A; Duran, C; Ferry, T; Hénard, S; Kernéis, S; Lazaro, P; Lebeaux, D; Wolff, M; Wyplosz, B | 1 |
| Carreno, J; Hunter, C; Lomaestro, B; Smiraglia, T; Tobin, E | 1 |
| Aoyama, N; Arakawa, S; Fujimoto, G; Kawahara, K; Kawahara, M; Rhee, EG; Sato, A; Yasuda, M; Yokokawa, R; Yoshinari, T | 1 |
1 trial(s) available for tazobactam and Adverse Drug Event
| Article | Year |
|---|---|
The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Japan; Male; Middle Aged; Pyelonephritis; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2019 |
3 other study(ies) available for tazobactam and Adverse Drug Event
| Article | Year |
|---|---|
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin | 2023 |
Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Salvage Therapy; Tazobactam; Treatment Outcome; Young Adult | 2017 |
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Creatinine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Incidence; Length of Stay; Male; Middle Aged; New York; Piperacillin; Retrospective Studies; Risk Assessment; Tazobactam; Vancomycin; Young Adult | 2018 |